Results 41 to 50 of about 172,377 (268)

Heavy Ion Physics at the LHC [PDF]

Nuclear Physics A, 2005
The ion-ion center of mass energies at the LHC will exceed that at RHIC by nearly a factor of 30, providing exciting opportunities for addressing unique physics issues in a completely new energy domain. Some highlights of this new physics domain are presented here. We briefly describe how these collisions will provide new insights into the high density,
openaire   +3 more sources

Golgi enzymes are retrieved from the plasma membrane to the trans‐Golgi network

FEBS Letters, EarlyView.
Golgi enzymes are traditionally considered resident proteins retained within the Golgi apparatus. Here, we demonstrate that a subset transiently reaches the cell surface and is subsequently retrieved to the trans‐Golgi network via retrograde transport. Using a nanobody‐based toolkit, we uncover a dynamic trafficking cycle of several Golgi enzymes.
Dominik P. Buser, Tina Junne
wiley   +1 more source

Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma

Chinese Journal of Cancer, 2016
Background After definitive chemoradiotherapy for non-metastatic nasopharyngeal carcinoma (NPC), more than 10% of patients will experience a local recurrence. Salvage treatments present significant challenges for locally recurrent NPC.
Lin Kong, Jing Gao, Jiyi Hu, Weixu Hu, Xiyin Guan, Rong Lu, Jiade J. Lu   +6 more
doaj   +1 more source

Analysis of delivery and recalculation of dose using DICOM treatment records

Radiation Medicine and Protection, 2022
Objective: A procedure has been proposed for patient-specific QA that, instead of comparing a measurement to the planned dose, compares the dose calculated by an independent system to the dose calculated by the planning system.
Z. Chen, M.F. Moyers, Y. Deng, H.L. Chen, J. Li, Z.M. Shen, J. Lin, Q. Wang, P. Yepes   +8 more
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Biological Guided Carbon-Ion Microporous Radiation to Tumor Hypoxia Area Triggers Robust Abscopal Effects as Open Field Radiation

Frontiers in Oncology, 2020
Recently, a growing number of studies focus on partial tumor irradiation to induce the stronger non-target effects. However, the value of partial volume carbon ion radiotherapy (CIRT) targeting hypoxic region of a tumor under imaging guidance as well as ...
Qingting Huang, Qingting Huang, Qingting Huang, Yun Sun, Yun Sun, Weiwei Wang, Weiwei Wang, Lien-Chun Lin, Lien-Chun Lin, Yangle Huang, Jing Yang, Jing Yang, Xiaodong Wu, Xiaodong Wu, Lin Kong, Lin Kong, Jiade Jay Lu, Jiade Jay Lu   +17 more
doaj   +1 more source

Jets in Heavy Ion Collisions [PDF]

Nuclear Physics A, 2007
4 pages, 3 postscript figures. Contributed to 38th Rencontres de Moriond on QCD and Hadronic Interactions, Les Arcs, France, 22-29 Mar ...
openaire   +2 more sources

Multistrangeness in heavy-ion collisions [PDF]

Proceedings of XXII International Baldin Seminar on High Energy Physics Problems — PoS(Baldin ISHEPP XXII), 2015
We discuss strangeness production in heavy-ion collisions in the broad energy range --- from SIS energies through AGS-SPS-RHIC and upto LHC energies. On several examples we demonstrate how the strange particle production can reveal information about the collision dynamics and about possible modifications of particle properties in medium.
Kolomeitsev, E. E., Melo, I., Tomasik, B., Voskresensky, D. N.   +3 more
openaire   +2 more sources

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology, EarlyView.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer   +7 more
wiley   +1 more source